Airway microbial-microbial interaction plays an important role in chronic 22 airway inflammatory diseases such as asthma. Moraxella is widely regarded as a human respiratory tract pathogen. We aimed to investigate the interactions among Moraxella, 24 Moraxellaceae (to which Moraxella belongs) and the airway microbiome in asthma.
INTRODUCTION
Asthma is a common airway condition characterized by chronic airway 54 inflammation that affects approximately 300 million people worldwide (1) . Recently, new culture-independent techniques have revealed that human airways harbour unique 56 microbial communities (including bacteria, fungi and viruses) that are closely correlated with chronic lung diseases such as asthma (2-4). The airway bacterial community in 58 asthma patients differs significantly from that of healthy individuals, with increased bacterial diversity, and more Proteobacteria, especially Moraxella, and fewer 60 Bacteroidetes (2).
Increasing evidence indicates that the airway bacterial microbiome plays an important 62 role in asthma. In a study of more than 600 infants at 1 month of age, Moraxella 4 catarrhalis, Haemophilus influenzae or Streptococcus pneumoniae cultured from the 64 oropharynx was correlated with increased risks of later wheezing and asthma (5) .
Culture-independent techniques have suggested that airway bacteria may cause asthma 66 and affect asthma activity (6). Several studies have indicated that airway bacteria are correlated with disease-related features and with the severity and therapeutic response of 68 asthma (7) (8) (9) (10) . Moraxella is currently regarded as an important and common pathogen in the human respiratory tract and is associated with a range of diseases such as sinusitis, 70 tracheitis, bronchitis and pneumonia in children and bronchitis, pneumonia and nosocomial infections in adults (11) , as well as with exacerbation of asthma (12) . In many 72 asthma patients, Moraxella catarrhalis is a dominant pathogen in the airway bacterial community (10) and is one of the most frequently isolated bacteria from sputum cultures 74 from patients with asthma exacerbations (13).
Recently, the presence of the fungal microbiome (mycobiome) in both healthy and 76 abnormal lungs has been increasingly recognized, and this mycobiome may impact the clinical course of chronic pulmonary diseases such as asthma (14). One previous study 78 identified differences in the airway mycobiome between asthma patients and healthy controls by using standard PCR techniques and pyrosequencing (15) .
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Airway bacterial-bacterial interactions are known to be associated with immune responses and airway inflammatory processes (16), thereby influencing the therapeutic 82 response and clinical outcome of lung diseases (17). Recent findings have provided insights on the airway bacterial-fungal interaction, which may contribute to the decline in 84 5 lung function and to disease progression (18) and is important in respiratory disease settings (19) . However, fungal-bacterial interactions in asthma have not been studied 86 extensively using culture-independent methods, and relatively little is known about the interaction among Moraxella, Moraxellaceae (to which Moraxella belongs) and the 88 airway mycobiome in asthma.
Recognizing that complex airway microbial communities and microbial-microbial 90 interactions play an increasingly important role in the development and progression of asthma (16, 19-21), we conducted a cross-sectional study to explore the alterations of 92 Moraxellaceae and Moraxella in asthma airways as well as the interactions among Moraxellaceae, Moraxella and the airway mycobiome. We aimed to provide new insights 94 on airway microbial characteristics, bacterial-fungal interactions, and the potential pathogenic mechanisms of asthma.
96

RESULTS
98
Clinical characteristics of the subjects. A total of 145 sputum samples were obtained from 116 asthma patients (55 stable asthma patients and 61 exacerbated asthma 100 patients) and 29 healthy subjects. After the sequencing analysis, samples from 128 and 145 participants were analysed for bacterial and fungal community composition data, 102 respectively. No significant differences were found in age, gender or smoking history between the healthy and asthmatic groups. Patients with stable asthma had more ICS 104 usage than patients with exacerbated asthma (P=0.017) ( Table 1) . In addition, we compared the airway bacterial and fungal community compositions 112 (relative abundance >1%) between asthma patients and healthy individuals (Table S1 ).
Asthma patients harboured a slightly higher abundance of Proteobacteria (P=0.222) and 114 an extremely increased abundance of Moraxellaceae, Moraxella and Moraxella otu19 in the airway than healthy individuals (Fig. 2 ). Among these selected bacterial and fungal 116 communities, more than 70% of the fungal community differed significantly between asthma patients and healthy individuals, especially Ascomycota, Basidiomycota, 118 Schizophyllaceae, Polyporaceae, Aspergillus, Schizophyllum, Candida and Meyerozyma, which were more prevalent in asthma patients, while only 20-45% of the bacterial 120 community differed significantly between the two groups, suggesting that the airway fungal community had a more varied and complex dysbiosis than the bacterial 122 community in asthma.
Bronchial hyperresponsiveness in outpatients with asthma may affect the airway 124 microbiome (22). Accordingly, we divided the asthmatic population into two subgroups-stable asthma and exacerbated asthma-according to disease activity.
However, the abundances of other families (average abundance >1%), such as Neisseriaceae and Pasteurellaceae, were not significantly increased, and some were even 
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We first focused on the bacterial diversity and found no significant relationships among Proteobacteria, Moraxellaceae, Moraxella, Moraxella otu19 and bacterial 150 diversity. However, a significantly positive correlation was found between Moraxellaceae and fungal diversity ( Fig. 3 ). Next, we investigated whether the airway fungal community 152 was related to fungal diversity and found that Basidiomycota, Schizophyllaceae, Schizophyllum, Schizophyllum commune otu6, Aspergillus otu5, Polyporaceae and 154 Candida were positively correlated with fungal diversity (all P values<0.001) ( Fig. S3 ).
Our findings suggested that Moraxellaceae had a greater influence on the fungal 156 community than the bacterial community in the asthma airway. Our findings revealed significant differences in airway microbial diversity and 202 community composition between asthma patients and healthy individuals. In agreement with previous studies, we found that asthma patients harboured a higher bacterial Moraxella is widely recognized as a pathogen in the airway and is associated with 212 several respiratory diseases such as asthma (11, 12 In the present study of airway microbial composition, Moraxellaceae had a greater influence on the α-diversity of fungi than bacteria. The dynamic interaction between 228 bacteria and fungi may have dramatic effects on airway inflammatory processes (18, 28) .
The correlation network showed positive correlations connecting Moraxellaceae and 230 Moraxella with Schizophyllaceae, Polyporaceae, Candida and Meyerozyma. 12 Additionally, Schizophyllum, which represents the vast majority of the family 232 Schizophyllaceae, is reported as a respiratory pathogen. Schizophyllum appears to enhance both the severity and the exacerbation frequency of asthma (29); sensitization to 234 Schizophyllum is an important risk factor for exacerbation frequency and a rapid decline in lung function in asthma (30). A previous study suggested that Candida may be 236 pathogenically important in patients with asthma (31) and associated with severe exacerbations of asthma requiring hospital admission (32) . We found that these However, no significant differences were found between stable asthma and 246 exacerbated asthma, suggesting that our outpatients with exacerbated asthma had disease that was extremely mild in severity without dyspnoea and easily controlled during 248 exacerbation (33) . Consequently, the microbial composition was similar between patients with exacerbated asthma and those with stable asthma.
250
Our study is strengthened by its relatively large sample size in China (9, 34) and by the combined exploration of airway bacterial and fungal communities. A limitation is the 252 13 cross-sectional design, which cannot capture the dynamic changes in the airway microbiome during the progression of asthma.
254
In conclusion, we have revealed for the first time an increase in fungal α-diversity and more severe dysbiosis of fungi than of bacteria in the asthma airway. Importantly, our The bacterial 16S rRNA genes and fungal ITS1 genes were amplified using the V4 region and ITS1 region of the genes, respectively. The amplicons were sequenced on an 294 15 iTorrent sequencing platform. Detailed information on the DNA amplification and purification steps was described in our previous studies (38, 39) . First, the barcode primers were trimmed and filtered if they contained ambiguous reads or 300 mismatches in the primer regions according to the BIPES protocol. Then, we removed sequences that had more than one mismatch in the 40-70 bp regions. Next, we screened 302 and removed chimaeras using UCHIME in de novo mode (41), and finally we generated the high-quality sequence reads of the 16S rRNA genes or ITS1 DNA genes. 304 We used the software pipeline "Quantitative Insights into Microbial Ecology" (QIIME) (1.9.1) to conduct subsequent analyses (42 We thank the patients, clinical doctors and microbiology staff who supported this 342 work. We thank American Journal Experts (AJE) for English language editing. 
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